Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmet Dogan

Showing results (351-360 of 371) with videos related to

Pageof 38
Sort By:
Nature Communications|October 3, 2024
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomasAnja Fischer, Thomas K Albert, Natalia Moreno, et al.
Nature Communications|May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
Cancer Discovery|November 15, 2015
Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsEli L Diamond, Benjamin H Durham, Julien Haroche, et al.
Cancer Discovery|April 21, 2026
SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilitiesBenedikt Pelzer, Cem Meydan, Isaac M Spiegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2023
Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient OutreachSeyram A Doe-Tetteh, Sabrina Y Camp, Dalicia Reales, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2025
Managing <i>Candida auris</i> fungemias: the results of a prospective and international studyHakan Erdem, Sena Şakir-Yildirim, Handan Ankarali, et al.
Blood|March 12, 2016
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical settingJie He, Omar Abdel-Wahab, Michelle K Nahas, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Nature Communications|October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencingRyan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Blood Advances|June 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKsJacob D Soumerai, Meghan C Thompson, Ahmet Dogan, et al.
Pageof 38

Showing results (351-360 of 371) with videos related to

Sort By:
Pageof 38
Nature Communications|October 3, 2024
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomasAnja Fischer, Thomas K Albert, Natalia Moreno, et al.
Nature Communications|May 24, 2018
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y Ng, Noriaki Yoshida, Amanda L Christie, et al.
Cancer Discovery|November 15, 2015
Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsEli L Diamond, Benjamin H Durham, Julien Haroche, et al.
Cancer Discovery|April 21, 2026
SPEN loss drives extra-follicular diffuse large B cell lymphoma with female-specific lethality and therapeutic vulnerabilitiesBenedikt Pelzer, Cem Meydan, Isaac M Spiegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2023
Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient OutreachSeyram A Doe-Tetteh, Sabrina Y Camp, Dalicia Reales, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2025
Managing <i>Candida auris</i> fungemias: the results of a prospective and international studyHakan Erdem, Sena Şakir-Yildirim, Handan Ankarali, et al.
Blood|March 12, 2016
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical settingJie He, Omar Abdel-Wahab, Michelle K Nahas, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Nature Communications|October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencingRyan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Blood Advances|June 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKsJacob D Soumerai, Meghan C Thompson, Ahmet Dogan, et al.
Pageof 38